CVKD
NASDAQ · Pharmaceuticals
Cadrenal Therapeutics Inc
$0.98
-0.02 (-2.00%)
Open$1.02
Previous Close$1.00
Day High$1.09
Day Low$0.98
52W High$13.11
52W Low$0.82
Volume—
Avg Volume79.0K
Market Cap3.50M
P/E Ratio—
EPS$-4.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,629.6% upside
Current
$0.98
$0.98
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.07M | 2.13M | 1.91M |
| Net Income | 662.5K | 666.1K | 461.6K |
| Profit Margin | 32.0% | 31.3% | 24.1% |
| EBITDA | 955.8K | 1.01M | 1.06M |
| Free Cash Flow | 570.9K | 515.8K | 427.8K |
| Rev Growth | +2.5% | +18.2% | +2.4% |
| Debt/Equity | 0.18 | 0.20 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |